Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain
sulfonamide or sulfonamide functionality at the 1-position are useful as immune
response modifiers. The compounds and compositions of the invention can induce
the biosynthesis of various cytokines and are useful in the treatment of a variety
of conditions including viral diseases and neoplastic diseases.
